Asthma trials in Canada
37 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma
- Where
- Montreal, Québec, Sherbrooke
- Age
- 18 years to 79 years
- People
- 150 worldwide
- Run by
- Université de Sherbrooke
See details and how to joinNCT07309614 - Phase 2Taking peopleA Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- Where
- Ajax, Hamilton, Kelowna, Montreal, Québec, Richmond, Saint-Laurent, Toronto, Windsor
- Age
- 18 years to 75 years
- People
- 531 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07219173 - Phase 4Taking peopleA Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
- Where
- Calgary, Trois-Rivières, Windsor
- Age
- 6 years and over
- People
- 2,500 worldwide
- Run by
- Sanofi
See details and how to joinNCT07556159 · EU 2025-524916-13-00 - Phase 3Taking peopleA Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
- Where
- Ajax, Québec, Trois-Rivières
- Age
- 18 years and over
- People
- 110 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07645248 - Phase 3Taking peopleRoll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
- Where
- Calgary, Hamilton, Toronto
- Age
- 6 years and over
- People
- 230 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07444567 - No phaseTaking peopleLungs on Fire: Wildfire Smoke, Incident Diseases, Susceptible Populations, and Community Values in Canada
- Where
- Vancouver
- Age
- 19 years to 80 years
- People
- 24
- Run by
- University of British Columbia
See details and how to joinNCT07536178 - Phase 3Taking peopleA Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
- Where
- Burlington, Edmonton, Hamilton, Montreal, Windsor
- Age
- 5 years to 11 years
- People
- 231 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06023589 - No phaseNot yet taking people in CanadaTesting the Effects of Temperature & Humidity on Children With and Without Asthma in an Environmental Climatic Chamber
- Where
- Oshawa
- Age
- 11 years to 18 years
- People
- 60
- Run by
- University of Ontario Institute of Technology
See details and how to joinNCT07864506 - Phase 2Taking peopleStudy of Inhaled ARO-RAGE in Allergen-induced Mild Asthma
- Where
- Calgary, Edmonton, Hamilton, Québec, Saskatoon, Vancouver
- Age
- 18 years to 65 years
- People
- 36
- Run by
- Arrowhead Pharmaceuticals
See details and how to joinNCT07241546 - No phaseNot yet taking people in CanadaSustained Asthma Remission and Reduced Relapse Using a Comprehensive Management Strategy (SARRE-COMS)
- Where
- London
- Age
- 18 years and over
- People
- 50
- Run by
- Hana Serajeddini
See details and how to joinNCT07816718 - No phaseTaking peopleCanadian Consortium on Airway Mucus Occlusions in Asthma, COPD and Chronic Cough
- Where
- Hamilton, London, Montreal, Ottawa, Québec, Sherbrooke, Vancouver
- Age
- 18 years and over
- People
- 240
- Run by
- McMaster University
See details and how to joinNCT06858748 - No phaseTaking peopleEarly Diagnosis and Treatment of Undiagnosed Asthma or COPD: THE UCAP 2 TRIAL
- Where
- Hamilton, Kingston, Ottawa, Québec, Saskatoon, Toronto
- Age
- 18 years and over
- People
- 420
- Run by
- Ottawa Hospital Research Institute
See details and how to joinNCT06392776 - Phase 2Enrolling by invitationLong-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
- Where
- Ajax, Hamilton, Sherbrooke, Trois-Rivières
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- Sanofi
See details and how to joinNCT06609239 · EU 2025-522896-27-00 - No phaseTaking peoplePharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Where
- Montreal, Toronto
- Age
- 0 years to 20 years
- People
- 5,000 worldwide
- Run by
- Duke University
See details and how to joinNCT04278404 - Phase 3Enrolling by invitationEfficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
- Where
- Burlington, Edmonton, Hamilton, Montreal, Sherbrooke, Vancouver
- Age
- 2 years to 5 years
- People
- 90 worldwide
- Run by
- Sanofi
See details and how to joinNCT06191315 · EU 2023-504331-41-00 - No phaseEnrolling by invitationeAMS-Eco: Implementation of a Tool for Climate Conscious Inhaler Prescribing
- Where
- Toronto
- Age
- 16 years and over
- People
- 95
- Run by
- University of Toronto
See details and how to joinNCT07638735 - No phaseTaking peopleStructure and Function MRI of Asthma
- Where
- London
- Age
- 18 years to 60 years
- People
- 200
- Run by
- Dr. Grace Parraga
See details and how to joinNCT02351141 - No phaseTaking peoplePAXT: Pulmonary Imaging of Mild Asthma Using 129Xe MRI and Tc-99-Labeled-Carbon-Imaging (Tc99CImaging)
- Where
- London
- Age
- 17 years to 35 years
- People
- 40
- Run by
- Dr. Grace Parraga
See details and how to joinNCT07143747 - No phaseNot yet taking people in CanadaREverse LuNg Airway and Vascular RemOdeling in Asthma ReMission (ReNORM)
- Where
- London
- Age
- 18 years to 80 years
- People
- 200
- Run by
- Western University, Canada
See details and how to joinNCT07174713 - Phase 4Taking peopleTezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA)
- Where
- Edmonton, St. Albert
- Age
- 18 years to 55 years
- People
- 100
- Run by
- University of Alberta
See details and how to joinNCT06705764 - Phase 3Taking peopleDepemokimab Asthma Imaging and Bronchoscopy Sub-Study
- Where
- Ajax, Hamilton, London
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06979323 · EU 2024-519976-19-00 - No phaseTaking peopleInfant RSV Immunity Study
- Where
- Vancouver
- Age
- Up to 6 months
- People
- 300
- Run by
- University of British Columbia
See details and how to joinNCT07653347 - No phaseTaking peopleN95 Masks for Lung Health While Golfing During Wildfire Season
- Where
- Saskatoon
- Age
- 18 years and over
- People
- 40
- Run by
- University of Saskatchewan
See details and how to joinNCT07620691 - No phaseTaking peopleInternational Severe Asthma Registry: Canadian Cohort
- Where
- Edmonton, Kingston, London, Montreal, Ottawa, Quebéc City, Saskatoon, Sherbrooke, Toronto, Vancouver
- Age
- 18 years and over
- People
- 714
- Run by
- University of British Columbia
See details and how to joinNCT04045587 - No phaseTaking peoplePROPULSION SANTE: Inflammometry to Improve the Diagnostic Trajectory in Situations of Suspected Asthma in Children and Adults
- Where
- Montreal, Sherbrooke
- Age
- 6 years and over
- People
- 1,500
- Run by
- Université de Sherbrooke
See details and how to joinNCT06981169